Aethlon Medical Q2 EPS $(2.60) Misses $(2.25) Estimate
Benzinga Newsdesk 6 days ago
NewsEarningsEarnings Misses
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Aethlon Medical (NASDAQ:AEMD) reported quarterly losses of $(2.60) per share which missed the analyst consensus estimate of $(2.25) by 15.56 percent. This is a 86.1 percent increase over losses of $(18.70) per share
Aethlon Medical (NASDAQ:AEMD) reported quarterly losses of $(2.60) per share which missed the analyst consensus estimate of $(2.25) by 15.56 percent. This is a 86.1 percent increase over losses of $(18.70) per share from the same period last year.
